Atransen Pharma株式会社 がシリーズAエクステンションラウンドのクロージングを完了しました。
1 known investors
Atransen Pharma is a pharmaceutical company developing cancer therapies that target amino acid transporters, specifically LAT1 (large neutral amino acid transporter), which cancer cells overexpress to take up amino acids needed for growth. It develops LAT1 inhibitors intended to suppress cancer cell growth with fewer side effects.
BiotechHealthtech